These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23393686)

  • 1. The pancreatic beta cells in human type 2 diabetes.
    Marchetti P; Bugliani M; Boggi U; Masini M; Marselli L
    Adv Exp Med Biol; 2012; 771():288-309. PubMed ID: 23393686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.
    Marchetti P; Dotta F; Lauro D; Purrello F
    Regul Pept; 2008 Feb; 146(1-3):4-11. PubMed ID: 17889380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-cell in human type 2 diabetes.
    Marchetti P; Lupi R; Del Guerra S; Bugliani M; Marselli L; Boggi U
    Adv Exp Med Biol; 2010; 654():501-14. PubMed ID: 20217512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pancreatic beta-cell in human Type 2 diabetes.
    Marchetti P; Del Prato S; Lupi R; Del Guerra S
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S3-6. PubMed ID: 16530127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dying beta cell originated messenger molecules in differentiation of pancreatic mesenchymal stem cells under glucotoxic and glucolipotoxic conditions.
    Gezginci-Oktayoglu S; Onay-Ucar E; Sancar-Bas S; Karatug-Kacar A; Arda ESN; Bolkent S
    J Cell Physiol; 2018 May; 233(5):4235-4244. PubMed ID: 29058819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of beta-cells with fibrotic islet destruction in type 2 diabetes mellitus.
    Kim JW; Ko SH; Cho JH; Sun C; Hong OK; Lee SH; Kim JH; Lee KW; Kwon HS; Lee JM; Song KH; Son HY; Yoon KH
    Front Biosci; 2008 May; 13():6022-33. PubMed ID: 18508639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
    Dayeh T; Ling C
    Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes.
    Weir GC; Marselli L; Marchetti P; Katsuta H; Jung MH; Bonner-Weir S
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():82-90. PubMed ID: 19817791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet β cell mass in diabetes and how it relates to function, birth, and death.
    Weir GC; Bonner-Weir S
    Ann N Y Acad Sci; 2013 Apr; 1281(1):92-105. PubMed ID: 23363033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An SCF
    Gorrepati KDD; He W; Lupse B; Yuan T; Maedler K; Ardestani A
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of Persisting β Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis.
    Cohrs CM; Panzer JK; Drotar DM; Enos SJ; Kipke N; Chen C; Bozsak R; Schöniger E; Ehehalt F; Distler M; Brennand A; Bornstein SR; Weitz J; Solimena M; Speier S
    Cell Rep; 2020 Apr; 31(1):107469. PubMed ID: 32268101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and pancreatic β-cells.
    Mazza S; Maffucci T
    Vitam Horm; 2014; 95():145-64. PubMed ID: 24559917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development and Analysis of Novel Therapeutic Targets to Improve Pancreatic β-Cell Function in Type 2 Diabetes].
    Kaneko YK
    Yakugaku Zasshi; 2016; 136(12):1623-1629. PubMed ID: 27904096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?
    Potter KJ; Westwell-Roper CY; Klimek-Abercrombie AM; Warnock GL; Verchere CB
    Diabetes; 2014 Jan; 63(1):12-9. PubMed ID: 24357689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-diabetic action of all-trans retinoic acid and the orphan G protein coupled receptor GPRC5C in pancreatic β-cells.
    Amisten S; Mohammad Al-Amily I; Soni A; Hawkes R; Atanes P; Persaud SJ; Rorsman P; Salehi A
    Endocr J; 2017 Mar; 64(3):325-338. PubMed ID: 28228611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
    Spijker HS; Song H; Ellenbroek JH; Roefs MM; Engelse MA; Bos E; Koster AJ; Rabelink TJ; Hansen BC; Clark A; Carlotti F; de Koning EJ
    Diabetes; 2015 Aug; 64(8):2928-38. PubMed ID: 25918235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of β-arrestin2 mediates pancreatic-islet dysfunction in mice.
    Zhang M; Zhu Y; Mu K; Li L; Lu J; Zhao J; Huang X; Wang C; Jia W
    Biochem Biophys Res Commun; 2013 Jun; 435(3):345-9. PubMed ID: 23660189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.